Proliferation of human colon cancer cells

Role of epidermal growth factor and transforming growth factorα

Shuang Huang, Jose M. Trujillo, Subhas Chakrabarty

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Human colon cancer cells produce and secrete a variety of polypeptide growth factors. The functional role of these growth factors, however, is poorly understood. Though the secretion of epidermal growth factor (EGF)‐like activity and EGF‐related molecules by human colon cancer cells in culture has been reported, it is not known whether colon cancer cells produce and secrete EGF, and the functional role of EGF in the growth control of these cells is also unknown. We have shown that EGF acts as a potent growth stimulator on the moderately differentiated Moser colon cancer cell line and as an inhibitor on the highly metastatic KM12SM cell line. In the present study, we show that EGF is produced by human colon cancer cells and characterize the levels of EGF mRNA expression and EGF protein secretion from 8 human colon cancer cell lines. The cell‐surface EGF receptors on these cell lines were also characterized by radiolabeled ligand binding and Scatchard analyses. All the cell lines expressed EGF mRNA and secreted EGF. Both high‐ and low‐affinity subtypes of EGF receptor were detected on 7 of the cell lines. These lines also secreted transforming growth factor (TGF)α. Some cell lines exhibited a proliferative response to treatment with either exogenous EGF or TGFα, while others did not respond to treatment with these growth factors. Antibody‐blocking experiments, using anti‐EGF or anti‐EGF receptor antibody, suggested that these cell lines could be broadly classified into 2 groups in terms of their autocrine or paracrine growth regulation via the cell‐surface EGF receptor: (1) cells that utilized EGF and/or TGFα; and (2) cells that did not utilize EGF or TGFα (via the cell‐surface receptor), even though they secreted abundant amounts of these growth factors. © 1992 Wiley‐Liss, Inc.

Original languageEnglish (US)
Pages (from-to)978-986
Number of pages9
JournalInternational Journal of Cancer
Volume52
Issue number6
DOIs
StatePublished - Jan 1 1992

Fingerprint

Transforming Growth Factors
Epidermal Growth Factor
Colonic Neoplasms
Cell Line
Intercellular Signaling Peptides and Proteins
Epidermal Growth Factor Receptor
Growth
Messenger RNA
Cell Culture Techniques
Ligands

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Proliferation of human colon cancer cells : Role of epidermal growth factor and transforming growth factorα. / Huang, Shuang; Trujillo, Jose M.; Chakrabarty, Subhas.

In: International Journal of Cancer, Vol. 52, No. 6, 01.01.1992, p. 978-986.

Research output: Contribution to journalArticle

Huang, Shuang ; Trujillo, Jose M. ; Chakrabarty, Subhas. / Proliferation of human colon cancer cells : Role of epidermal growth factor and transforming growth factorα. In: International Journal of Cancer. 1992 ; Vol. 52, No. 6. pp. 978-986.
@article{894a2ef4e7d94b2fb9feccad0d0abe2a,
title = "Proliferation of human colon cancer cells: Role of epidermal growth factor and transforming growth factorα",
abstract = "Human colon cancer cells produce and secrete a variety of polypeptide growth factors. The functional role of these growth factors, however, is poorly understood. Though the secretion of epidermal growth factor (EGF)‐like activity and EGF‐related molecules by human colon cancer cells in culture has been reported, it is not known whether colon cancer cells produce and secrete EGF, and the functional role of EGF in the growth control of these cells is also unknown. We have shown that EGF acts as a potent growth stimulator on the moderately differentiated Moser colon cancer cell line and as an inhibitor on the highly metastatic KM12SM cell line. In the present study, we show that EGF is produced by human colon cancer cells and characterize the levels of EGF mRNA expression and EGF protein secretion from 8 human colon cancer cell lines. The cell‐surface EGF receptors on these cell lines were also characterized by radiolabeled ligand binding and Scatchard analyses. All the cell lines expressed EGF mRNA and secreted EGF. Both high‐ and low‐affinity subtypes of EGF receptor were detected on 7 of the cell lines. These lines also secreted transforming growth factor (TGF)α. Some cell lines exhibited a proliferative response to treatment with either exogenous EGF or TGFα, while others did not respond to treatment with these growth factors. Antibody‐blocking experiments, using anti‐EGF or anti‐EGF receptor antibody, suggested that these cell lines could be broadly classified into 2 groups in terms of their autocrine or paracrine growth regulation via the cell‐surface EGF receptor: (1) cells that utilized EGF and/or TGFα; and (2) cells that did not utilize EGF or TGFα (via the cell‐surface receptor), even though they secreted abundant amounts of these growth factors. {\circledC} 1992 Wiley‐Liss, Inc.",
author = "Shuang Huang and Trujillo, {Jose M.} and Subhas Chakrabarty",
year = "1992",
month = "1",
day = "1",
doi = "10.1002/ijc.2910520625",
language = "English (US)",
volume = "52",
pages = "978--986",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Proliferation of human colon cancer cells

T2 - Role of epidermal growth factor and transforming growth factorα

AU - Huang, Shuang

AU - Trujillo, Jose M.

AU - Chakrabarty, Subhas

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Human colon cancer cells produce and secrete a variety of polypeptide growth factors. The functional role of these growth factors, however, is poorly understood. Though the secretion of epidermal growth factor (EGF)‐like activity and EGF‐related molecules by human colon cancer cells in culture has been reported, it is not known whether colon cancer cells produce and secrete EGF, and the functional role of EGF in the growth control of these cells is also unknown. We have shown that EGF acts as a potent growth stimulator on the moderately differentiated Moser colon cancer cell line and as an inhibitor on the highly metastatic KM12SM cell line. In the present study, we show that EGF is produced by human colon cancer cells and characterize the levels of EGF mRNA expression and EGF protein secretion from 8 human colon cancer cell lines. The cell‐surface EGF receptors on these cell lines were also characterized by radiolabeled ligand binding and Scatchard analyses. All the cell lines expressed EGF mRNA and secreted EGF. Both high‐ and low‐affinity subtypes of EGF receptor were detected on 7 of the cell lines. These lines also secreted transforming growth factor (TGF)α. Some cell lines exhibited a proliferative response to treatment with either exogenous EGF or TGFα, while others did not respond to treatment with these growth factors. Antibody‐blocking experiments, using anti‐EGF or anti‐EGF receptor antibody, suggested that these cell lines could be broadly classified into 2 groups in terms of their autocrine or paracrine growth regulation via the cell‐surface EGF receptor: (1) cells that utilized EGF and/or TGFα; and (2) cells that did not utilize EGF or TGFα (via the cell‐surface receptor), even though they secreted abundant amounts of these growth factors. © 1992 Wiley‐Liss, Inc.

AB - Human colon cancer cells produce and secrete a variety of polypeptide growth factors. The functional role of these growth factors, however, is poorly understood. Though the secretion of epidermal growth factor (EGF)‐like activity and EGF‐related molecules by human colon cancer cells in culture has been reported, it is not known whether colon cancer cells produce and secrete EGF, and the functional role of EGF in the growth control of these cells is also unknown. We have shown that EGF acts as a potent growth stimulator on the moderately differentiated Moser colon cancer cell line and as an inhibitor on the highly metastatic KM12SM cell line. In the present study, we show that EGF is produced by human colon cancer cells and characterize the levels of EGF mRNA expression and EGF protein secretion from 8 human colon cancer cell lines. The cell‐surface EGF receptors on these cell lines were also characterized by radiolabeled ligand binding and Scatchard analyses. All the cell lines expressed EGF mRNA and secreted EGF. Both high‐ and low‐affinity subtypes of EGF receptor were detected on 7 of the cell lines. These lines also secreted transforming growth factor (TGF)α. Some cell lines exhibited a proliferative response to treatment with either exogenous EGF or TGFα, while others did not respond to treatment with these growth factors. Antibody‐blocking experiments, using anti‐EGF or anti‐EGF receptor antibody, suggested that these cell lines could be broadly classified into 2 groups in terms of their autocrine or paracrine growth regulation via the cell‐surface EGF receptor: (1) cells that utilized EGF and/or TGFα; and (2) cells that did not utilize EGF or TGFα (via the cell‐surface receptor), even though they secreted abundant amounts of these growth factors. © 1992 Wiley‐Liss, Inc.

UR - http://www.scopus.com/inward/record.url?scp=0026621875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026621875&partnerID=8YFLogxK

U2 - 10.1002/ijc.2910520625

DO - 10.1002/ijc.2910520625

M3 - Article

VL - 52

SP - 978

EP - 986

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -